• 17 January, 2026

India defines pathway for biosimilars development

July 6, 2012 | Friday | Regulatory | By BioSpectrum Bureau

India provides clear pathway for biosimilars development

India's new set of guidelines for biosimilars will provide a clear pathway to companies

India's new set of guidelines for biosimilars will provide a clear pathway to companies

Sign up for the editor pick and get articles like this delivered right to your inbox.

+Country Code-Phone Number(xxx-xxxxxxx)

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Podcast

Most Read

Survey Box

Is the future of mRNA being built in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls